We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+4.36%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$13.8B
AUM Growth
+$1.02B
(+8%)
Cap. Flow
+$618M
Cap. Flow
% of AUM
4.47%
Top 10 Holdings %
Top 10 Hldgs %
12.42%
Holding
2,126
New
119
Increased
1,428
Reduced
493
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$22.5M |
| 2 |
Walmart Inc
WMT
|
+$16.8M |
| 3 |
IBM
IBM
|
+$16.1M |
| 4 |
Johnson & Johnson
JNJ
|
+$15.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$26.9M |
| 2 |
DEG
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
|
+$14.8M |
| 3 |
NJ
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
|
+$10.2M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$8.5M |
| 5 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$6.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.94% |
| 4 | Consumer Staples | 9.08% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAG
1876
DELISTED
AMAG Pharmaceuticals
AMAG
| $228K | ﹤0.01% |
+9,322
| New | +$233K |
|
|
BFS
1877
Saul Centers
BFS
$858M
| $227K | ﹤0.01% |
3,412
+19
| +0.6% | +$1.25K |
|
1878
HealthEquity
HQY
$8.71B
| $227K | ﹤0.01% |
+6,002
| New | +$190K |
|
|
OKSB
1879
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $227K | ﹤0.01% |
11,916
+1,833
| +18% | +$34.5K |
|
1880
Hyster-Yale Materials Handling
HY
$576M
| $226K | ﹤0.01% |
3,751
+316
| +9% | +$17.9K |
|
|
CLNY
1881
DELISTED
Colony Capital, Inc.
CLNY
| $226K | ﹤0.01% |
12,389
-43
| -0.3% | -$761 |
|
|
DOC
1882
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $226K | ﹤0.01% |
+10,471
| New | +$221K |
|
|
MIC
1883
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $225K | ﹤0.01% |
+2,700
| New | +$214K |
|
|
BKS
1884
DELISTED
Barnes & Noble
BKS
| $224K | ﹤0.01% |
19,789
-441
| -2% | -$5.32K |
|
|
CYNO
1885
DELISTED
Cynosure, Inc. Class A
CYNO
| $224K | ﹤0.01% |
4,401
+263
| +6% | +$13.7K |
|
1886
MarineMax
HZO
$748M
| $223K | ﹤0.01% |
+10,622
| New | +$209K |
|
1887
PBF Energy
PBF
$7.49B
| $222K | ﹤0.01% |
9,816
-15
| -0.2% | -$337 |
|
1888
Rayonier Advanced Materials
RYAM
$562M
| $222K | ﹤0.01% |
16,605
-215
| -1% | -$2.78K |
|
1889
Sonic Automotive
SAH
$3.56B
| $221K | ﹤0.01% |
+11,743
| New | +$208K |
|
|
ASRT
1890
DELISTED
Assertio
ASRT
| $220K | ﹤0.01% |
+147
| New | +$185K |
|
1891
Euronet Worldwide
EEFT
$3.19B
| $220K | ﹤0.01% |
+2,694
| New | +$206K |
|
1892
Fossil Group
FOSL
$260M
| $220K | ﹤0.01% |
7,913
-183
| -2% | -$5.41K |
|
1893
Halozyme
HALO
$9.88B
| $220K | ﹤0.01% |
18,178
+5,926
| +48% | +$60.6K |
|
|
GNRT
1894
DELISTED
Gener8 Maritime, Inc.
GNRT
| $220K | ﹤0.01% |
+42,878
| New | +$231K |
|
1895
Acco Brands
ACCO
$399M
| $219K | ﹤0.01% |
22,736
+5,079
| +29% | +$52.2K |
|
1896
Adtran
ADTN
$675M
| $219K | ﹤0.01% |
11,461
-546
| -5% | -$10.1K |
|
1897
Valley National Bancorp
VLY
$7.9B
| $219K | ﹤0.01% |
22,546
+506
| +2% | +$4.72K |
|
1898
Banner Corp
BANR
$2.38B
| $218K | ﹤0.01% |
4,985
+86
| +2% | +$3.7K |
|
1899
CVR Energy
CVI
$3.48B
| $218K | ﹤0.01% |
15,861
-3,549
| -18% | -$51K |
|
1900
Piper Sandler
PIPR
$4.99B
| $216K | ﹤0.01% |
+17,888
| New | +$195K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q3 2016 Portfolio in Review
As of Q3 2016, Aperio Group held 2,126 positions worth $13.8B, up 8% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $618M of net new capital in Q3 2016, opening 119 new positions and adding to 1,428 existing holdings. Its largest new stake was Fortive: 345,212 shares worth $11.1M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.5M trimmed.
- Aperio Group's largest Q3 2016 buy was Fortive: 345,212 shares worth $11.1M.
- Aperio Group added most to Apple in Q3 2016, an estimated $22.5M increase.
- Aperio Group's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $8.5M.
- Aperio Group fully exited EMC CORPORATION in Q3 2016, selling an estimated $26.9M.
- Aperio Group's ten largest holdings make up 12% of its $13.8B portfolio in Q3 2016.
- Aperio Group opened 119 new positions and closed 63 in Q3 2016.
- Aperio Group's portfolio value rose 8% quarter-over-quarter to $13.8B.
Based on Aperio Group's 13F filing for Q3 2016, filed 2 Nov 2016.